These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38681783)

  • 1. Protein-S-100-beta is increased in patients with decompensated cirrhosis admitted to ICU.
    Weiss N; Tripon S; Mallet M; Imbert-Bismut F; Sakka M; Bonnefont-Rousselot D; Sultanik P; Mouri S; Rudler M; Thabut D
    J Intensive Med; 2024 Apr; 4(2):222-230. PubMed ID: 38681783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study.
    Weiss N; Tripon S; Lodey M; Guiller E; Junot H; Monneret D; Mayaux J; Brisson H; Mallet M; Rudler M; Imbert-Bismut F; Thabut D;
    Fundam Clin Pharmacol; 2018 Apr; 32(2):209-215. PubMed ID: 29239015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systemic mechanism of increased transendothelial migration of leukocytes through the blood-brain barrier in hepatic encephalopathy.
    Schaefer A; Journaux M; Mourabit HE; Mouri S; Wendum D; Lasnier E; Couraud PO; Housset C; Thabut D; Rudler M; Weiss N
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101801. PubMed ID: 34517149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of General and Liver-Specific Prognostic Scores in Their Ability to Predict Mortality in Cirrhotic Patients Admitted to the Intensive Care Unit.
    Costa E Silva PP; Codes L; Rios FF; Esteve CP; Valverde Filho MT; Lima DOC; de Almeida Filho GF; Morais MCA; Lima BC; Chagas PBO; Boa-Sorte N; Bittencourt PL
    Can J Gastroenterol Hepatol; 2021; 2021():9953106. PubMed ID: 34608435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CLIF-C ACLF Score and MELD Score in Predicting ICU Mortality in Patients with Acute-On-Chronic Liver Failure.
    Ramzan M; Iqbal A; Murtaza HG; Javed N; Rasheed G; Bano K
    Cureus; 2020 Feb; 12(2):e7087. PubMed ID: 32226688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D; Zuo H; Liu L; Dong J; Ding L
    Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of MELD-lactate clearance scoring system in predicting death risk of critically ill cirrhotic patients.
    Li X; Gong M; Fu S; Zhang J; Wu S
    BMC Gastroenterol; 2022 Jun; 22(1):280. PubMed ID: 35658837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
    Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
    World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal insufficiency in decompensated cirrhotic patients without infection: prevalence, predictors and impact on mortality.
    Nandish HK; Arun CS; Nair HR; Gopalakrishna R; Kumar H; Venu RP
    J R Coll Physicians Edinb; 2019 Dec; 49(4):277-281. PubMed ID: 31808452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
    Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
    Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
    World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.
    Weiss N; Rosselli M; Mouri S; Galanaud D; Puybasset L; Agarwal B; Thabut D; Jalan R
    Metab Brain Dis; 2017 Apr; 32(2):369-376. PubMed ID: 27730496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites.
    Hu XG; Yang XX; Lu J; Li G; Dai JJ; Wang JM; Deng Y; Feng R
    World J Gastrointest Surg; 2024 Feb; 16(2):481-490. PubMed ID: 38463353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the predictive value of scoring systems on the prognosis of cirrhotic patients with suspected infection.
    Lan P; Wang SJ; Shi QC; Fu Y; Xu QY; Chen T; Yu YX; Pan KH; Lin L; Zhou JC; Yu YS
    Medicine (Baltimore); 2018 Jul; 97(28):e11421. PubMed ID: 29995791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of different prognostic scores in liver transplantation decision-making for acute-on-chronic liver failure].
    Xu MM; Wu Y; Li SS; Geng N; Lu W; Duan BW; Duan ZP; Li GM; Li J; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):574-581. PubMed ID: 37400380
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy.
    Kim MJ; Kim JH; Jung JH; Kim SE; Kim HS; Jang MK; Park SH; Lee MS; Suk KT; Kim DJ; Choi EK; Park JW
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Survival for Patients With Cirrhosis and Organ Failure in Liver Intensive Care and Validation of the Chronic Liver Failure-Sequential Organ Failure Scoring System.
    McPhail MJ; Shawcross DL; Abeles RD; Chang A; Patel V; Lee GH; Abdulla M; Sizer E; Willars C; Auzinger G; Bernal W; Wendon JA
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1353-1360.e8. PubMed ID: 25240417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.